Skip to main content
. Author manuscript; available in PMC: 2016 Apr 20.
Published in final edited form as: Thorax. 2014 Sep 25;70(3):229–236. doi: 10.1136/thoraxjnl-2014-205718

Table 3. Treatment comparisons between the US and the UK.

US UK US-UK Difference (95% CI) p-value

Treatment Total n n(%) Total n n(%)

Hypertonic saline; n(%)
<18 years 13412 5489 (40.9) 39073 327 (8.4) 32.6 (31.4, 33.8) <0.001
≥18 years 10803 5594 (51.8) 870 571 (14.8) 37.0 (35.6, 38.5) <0.001

Any nebulised antibiotic, n(%)
<18 years 13412 6000 (44.7) 3907 1674 (42.9) 1.9 (0.1, 3.7) 0.036
≥18 years 10803 7079 (65.5) 3870 2396 (61.9) 3.6 (1.8, 5.4) <0.001

rhDNase; n(%)
<18 years 13412 10360 (77.2) 3907 1382 (35.4) 41.9 (40.2, 43.5) <0.001
≥18 years 10803 8126 (75.2) 3870 2009 (51.9) 23.3 (21.5, 25.1) <0.001

Macrolides, n(%)
<18 years 13412 4505 (33.6) 3907 942 (24.1) 9.5 (7.9, 11.0) <0.001
≥18 years 10803 7061 (65.4) 3870 2373 (61.3) 4.0 (2.3, 5.8) <0.001